Patrick Lin, Chief Business - Strategy Officer at Processa Pharmaceuticals, Inc. (PCSA), bought 31,250 shares at $4.00 ($125K) on 2020-10-01, disclosed to the SEC on 2020-10-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| PCSA | BUY | 2026-06-01 | $4K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $4K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $4K | — | Filing → |